Episode 8: An Espresso-Shot on Hypertrophic Cardiomyopathy Episode 8: An Espresso-Shot on Hypertrophic Cardiomyopathy
Drs Michelle Kittleson and Carolyn Ho have a delightful discussion about effective diagnosis and management for individuals with hypertrophic cardiomyopathy.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 6, 2023 Category: Consumer Health News Tags: Cardiology InDiscussion Source Type: news
Glasgow mother who received heart transplant reveals how her daughter used Amazon Alexa for help
A Glasgow mum has revealed how her six-year-old daughter was able to save her life twice using Amazon's Alexa. She has hypertrophic cardiomyopathy and received a transplant. (Source: the Mail online | Health)
Source: the Mail online | Health - July 3, 2023 Category: Consumer Health News Source Type: news
Lifesaving new drug offers hope to 7,000 Britons a year who suffer a dangerous form of heart strain
Mavacamten - also known as Camzyos - is the first medicine developed specifically to tackle obstructive hypertrophic cardiomyopathy, a serious disorder that affects about 7,000 people in the UK. (Source: the Mail online | Health)
Source: the Mail online | Health - June 3, 2023 Category: Consumer Health News Source Type: news
New drug could help thousands with chronic heart disease in England
Nice approves mavacamten, used to treat obstructive hypertrophic cardiomyopathy, in draft guidance to NHSA first-of-its-kind treatment targeting a chronic heart disease could offer a “greater hope” to thousands of people living with the condition.The National Institute for Health and Care Excellence (Nice) has approved the use of mavacamten in draft guidance to the NHS. It would be used to treat those with obstructive hypertrophic cardiomyopathy (HCM), with about 7,000 people expected to benefit.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 2, 2023 Category: Science Authors: Andrew Gregory Health editor Tags: Heart disease Health NHS National Institute for Health and Care Excellence England UK news Society Source Type: news
Vigorous Exercise Not Harmful With Hypertrophic Cardiomyopathy
WEDNESDAY, May 24, 2023 -- Among individuals with hypertrophic cardiomyopathy (HCM), vigorous exercise is not associated with a higher rate of death or life-threatening arrhythmias such as resuscitated sudden cardiac arrest, arrhythmic syncope, or... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 24, 2023 Category: Pharmaceuticals Source Type: news
Exercise No Threat to People With an Inherited Form of Enlarged Heart
FRIDAY, May 19, 2023 -- People with the rare heart disorder hypertrophic cardiomyopathy (HCM) can safely engage in vigorous exercise, according to new research.
This finding could lead to fewer activity restrictions for people with this condition,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 19, 2023 Category: General Medicine Source Type: news
Vigorous exercise not tied to increased risk of adverse events in rare heart condition
NIH-supported study could lead to less restrictions for those with hypertrophic cardiomyopathy. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - May 17, 2023 Category: American Health Source Type: news
Changing Risk Stratification in Hypertrophic Cardiomyopathy? Changing Risk Stratification in Hypertrophic Cardiomyopathy?
Data indicate that extended ECG monitoring detects a higher incidence of clinically relevant arrhythmias than 24-hour monitoring.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 16, 2023 Category: Cardiology Tags: Cardiology News Source Type: news
Surprisingly More NSVT Using Extended ECG Monitoring in HCM Surprisingly More NSVT Using Extended ECG Monitoring in HCM
With implications for sudden-death risk assessment, 30-day compared to 24-hour monitoring may detect far more clinically important arrhythmias in patients with hypertrophic cardiomyopathy.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - May 9, 2023 Category: Internal Medicine Tags: Cardiology News Source Type: news
Yale study gives insights on hypertrophic cardiomyopathy management
Until recently, patients with the rare and potentially deadly cardiac condition were advised to avoid vigorous exercise. A new, Yale-led study finds otherwise. (Source: Yale Science and Health News)
Source: Yale Science and Health News - March 13, 2023 Category: Universities & Medical Training Source Type: news
Telehealth use for behavioral health increases 45X since pandemic onset and more digital health briefs
Viz.ai also announced an agreement with Bristol Myers Squibb to identify patients with hypertrophic cardiomyopathy. (Source: mobihealthnews)
Source: mobihealthnews - March 10, 2023 Category: Information Technology Source Type: news
Time to Ease Exercise Restrictions in Patients With HCM? Time to Ease Exercise Restrictions in Patients With HCM?
Electrophysiologists John Mandrola, MD. and Rachel Lampert, MD, review the LIVE-HCM study comparing vigorous and nonvigorous exercise in people with hypertrophic cardiomyopathy.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 10, 2023 Category: Consumer Health News Tags: Cardiology Expert Interview Source Type: news
Even Vigorous Exercise Appears Safe for HCM Patients: LIVE-HCM Even Vigorous Exercise Appears Safe for HCM Patients: LIVE-HCM
Patients with hypertrophic cardiomyopathy should no longer be routinely saddled with restriction from intense exercise or sports, which don ' t add to their arrhythmic risk, a large study suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 8, 2023 Category: Consumer Health News Tags: Cardiology News Source Type: news
Cytokinetics heart failure drug turned back by FDA
The company is turning its attention to another drug, which is in a late-stage clinical trial in a genetic heart disease, obstructive hypertrophic cardiomyopathy, that in 1993 killed Boston Celtics star Reggie Lewis. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 1, 2023 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
Sudden Cardiac Death in HCM Often Preceded by Symptoms
WEDNESDAY, Sept. 28, 2022 -- A majority of cases of sudden cardiac death (SCD) with hypertrophic cardiomyopathy (HCM) present with possible cardiac symptoms before death, and a considerable proportion have a known cardiac disorder prior to death,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 28, 2022 Category: Pharmaceuticals Source Type: news
